Radiopharm Theranostics Limited

ASX:RAD Voorraadrapport

Marktkapitalisatie: AU$52.2m

Radiopharm Theranostics Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Radiopharm Theranostics has a total shareholder equity of A$27.4M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$72.0M and A$44.7M respectively.

Belangrijke informatie

0%

Verhouding schuld/eigen vermogen

AU$0

Schuld

Rente dekkingsration/a
ContantAU$18.58m
AandelenAU$27.35m
Totaal verplichtingenAU$44.68m
Totaal activaAU$72.04m

Recente financiële gezondheidsupdates

Recent updates

We're A Little Worried About Radiopharm Theranostics' (ASX:RAD) Cash Burn Rate

Jan 06
We're A Little Worried About Radiopharm Theranostics' (ASX:RAD) Cash Burn Rate

Here's Why Radiopharm Theranostics (ASX:RAD) Must Use Its Cash Wisely

Sep 02
Here's Why Radiopharm Theranostics (ASX:RAD) Must Use Its Cash Wisely

Analyse van de financiële positie

Kortlopende schulden: RAD's short term assets (A$22.8M) exceed its short term liabilities (A$17.6M).

Langlopende schulden: RAD's short term assets (A$22.8M) do not cover its long term liabilities (A$27.1M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: RAD is debt free.

Schuld verminderen: RAD had no debt 5 years ago.


Balans


Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: RAD has less than a year of cash runway based on its current free cash flow.

Voorspelling contante baan: RAD has less than a year of cash runway if free cash flow continues to reduce at historical rates of 18.4% each year


Ontdek gezonde bedrijven